Paul Sagan

Insider profile

Currently holds positions in EMC Corp, Akamai Technologies Inc, VMware Inc and Moderna Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 50% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director EMC Corp Dec. 20, 2007 -
Independent Director Akamai Technologies Inc Jan. 1, 2015 -
Lead Independent Director VMware Inc Feb. 1, 2015 -
Non-Executive Independent Director Moderna Inc June 1, 2018 -
Independent Director iRobot Corp Feb. 1, 2010 - June 12, 2015
Independent Director VMware Inc April 7, 2014 - Feb. 1, 2015
Executive Vice Chairman of the Board Akamai Technologies Inc Jan. 1, 2013 - Jan. 1, 2015
Board Member Dow Jones & Company Inc None -
President, Chief Executive Officer, Director Akamai Technologies Inc Sept. 1, 2011 - Dec. 1, 2012
Paul Sagan's trades of Moderna Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
479.82
Quantity 17,488
Value US$3,019,423
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
404.66
Quantity 27,577
Value US$3,099,064
US Moderna Inc (MRNA)
Transaction date
Purchase
Price
300.86
Quantity 50,167 +20.6%
Value US$2,634,068
US Moderna Inc (MRNA)
Transaction date
Planned sale
Price
314.90
Quantity 2,250 -13.1%
Value US$708,525
US Moderna Inc (MRNA)
Transaction date
Purchase
Price
19.00
Quantity 52,631 +14.3%
Value US$999,989
Transaction date
Planned sale
Price
55.06
Quantity 23,255 -37.4%
Value US$1,280,420
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-18
US Moderna Inc (MRNA)
PrS Proposed sale
17,488
479.82
US$3,019,423 		17,488 479.82 US$3,019,423
2026-05-08 2026-05-08
US Moderna Inc (MRNA)
PrS Proposed sale
27,577
404.66
US$3,099,064 		27,577 404.66 US$3,099,064
2025-03-04 2025-03-03
US Moderna Inc (MRNA)
B Purchase
50,167 +20.6%
300.86
US$2,634,068 		50,167 +20.6% 300.86 US$2,634,068
2021-10-15 2021-10-13
US Moderna Inc (MRNA)
PlS Planned sale
2,250 -13.1%
314.90
US$708,525 		2,250 -13.1% 314.90 US$708,525
2020-02-18 2020-02-14
US Moderna Inc (MRNA)
B Purchase
52,631 +14.3%
19.00
US$999,989 		52,631 +14.3% 19.00 US$999,989
2016-03-10 2016-03-09
PlS Planned sale
23,255 -37.4%
55.06
US$1,280,420 		23,255 -37.4% 55.06 US$1,280,420